INDIVIDUAL VARIABILITY OF HALF-LIFE IN TERMINAL(OR β) PHASE OF DRUG

MOTOSABURO MASUYAMA

doi:10.20604/00001797

January 1, 1979Open Access

INDIVIDUAL VARIABILITY OF HALF-LIFE IN TERMINAL(OR β) PHASE OF DRUG

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research investigates how the variability in drug half-lives affects their decay rates among individuals.
Data comparison from two reference books
Analysis of half-lives based on decay rates
Evaluation of standard deviations in drug activity
Variability in half-lives suggests significant differences among individuals
Potential inaccuracies in data due to sample size limitations
Observations highlight the complexity of drug metabolism

Implication

Analysis explores the variability of drug decay rates, suggesting implications for dosing strategies.

Abstract

Since the half-life Tl2f ag is gWby 2Wz2 the indiVidrvariability of the decay rate k defined Ide standaTd deviatinf Zksis gsdatinf Z2The fbllowing table is constructed based on the data in two reference books 13 Since the size of eadh sample is not given and ses tbe fai1y1ditif the ettfu my not give the true variability of the individua1activity of the drugO1 0n the ccn logarithmic scale Nbte that is dimensionless

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

MOTOSABURO MASUYAMA (1979) studied this question.

synapsesocial.com/papers/69cf59635a333a8214609f77 https://doi.org/10.20604/00001797

View Full Paper

Ask AI

Bookmark

Share

INDIVIDUAL VARIABILITY OF HALF-LIFE IN TERMINAL(OR β) PHASE OF DRUG

Key Points

Implication

Abstract

Discussion

Cite This Study

INDIVIDUAL VARIABILITY OF HALF-LIFE IN TERMINAL(OR β) PHASE OF DRUG

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers